117 results
8-K
EX-10.3
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Borrower’s disinterested directors; provided
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Borrower’s disinterested directors … Securities (selected by holders of the majority of the Registrable Securities requesting such registration). In addition, the Company shall
8-K
EX-10.1
iieqp6di0yf u05g
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.5
2neaexidzpsuov6q
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.6
jf30wp un
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
ysski410u3
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-4.1
6lpbf3x2zg kgqaowqn
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
2xefj e1zip7vg4p92e
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.3
vfbit9r
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
hwog4bea
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
0vtz629ic22kxt
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.3
9ewaag5g
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
7tp4mc
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
9dm8ga0r
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm